Adebrelimab Plus Apatinib Combined With SOX Regimen as Conversion Therapy for Gastric Cancer
Clinical trial NCT07353684 · RECRUITING
Trial details
- NCT number
- NCT07353684
- Sponsor
- Beijing Friendship Hospital
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-05-11
- Primary completion
- 2028-02-01
- Enrollment
- 49
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.